English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Conference Paper

The oligomer modulator anle138b is effective in the prodromal phase of a transgenic mouse model of Parkinson's disease.

MPS-Authors
/persons/resource/persons45923

Ryazanov,  S.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15438

Leonov,  A.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15147

Griesinger,  C.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

External Resource
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Prix, C., Schmidt, F., Levin, J., Schinke, K., Shi, S., Ryazanov, S., et al. (2014). The oligomer modulator anle138b is effective in the prodromal phase of a transgenic mouse model of Parkinson's disease. European Journal of Neurology, 21(Suppl. 1), 170-170.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0019-F61D-A
Abstract
There is no abstract available